Kurser indlæses...

Prognose

Vi har ingen analytikerdata for denne virksomhed.

Diskussioner i communityet

Monatszahler mit guter Dividende?
Sylvia V i Schnack

2 44

Start diskussion

Nyheder Til nyhedsfeedet

Savaria surpasses Q2 forecasts thanks to improved margins

Savaria reported adjusted earnings of CAD 0.35 per share and revenue of CAD 245.8m for Q2 2026, both slightly above estimates, with revenue up 8.4%. The adjusted EBITDA margin improved to 21.1%; the accessibility segment posted the strongest margin at 23.6%, while the patient care segment suffered from raw material costs. Management reaffirmed its target of roughly 12% annual revenue growth through 2030 and EBITDA margins above 20%, along with further investments and potential acquisitions. The stock rose moderately after the results and is trading near its 52-week high. » Mere på de.investing.com
Savaria beats Q1 2026 expectations for revenue and EPS, but stock falls

Savaria reported Q1 2026 revenue of CAD 235.5m (+7%) and EPS of CAD 0.31, both slightly above analyst estimates. Adjusted EBITDA rose 20.3% and gross margin improved to 38.9%, which is attributed to the Savaria One operational program. Despite the positive results, the stock fell 1.59% after the release; management remains optimistic and plans product launches in Europe and North America. The board and analysts see risks from currency fluctuations, market saturation in stairlifts and macroeconomic pressure. » Mere på de.investing.com
Savaria surpasses Q4 expectations with strong revenue and margin growth

Savaria reported Q4 EPS of CAD 0.37, well above the analyst estimate of CAD 0.3239, with revenue of CAD 241.8 million versus expected CAD 237.29 million. The adjusted EBITDA margin rose to a record 21.2% and adjusted EBITDA grew 20% year over year. The stock then climbed 4.03% to CAD 24.32; the company expects further growth from the "Savaria One" program as well as expansion in accessibility and patient care. » Mere på de.investing.com
Savaria: Q3 EBITDA margin above 20%, EPS beats expectations

Savaria reported Q3 2025 EPS of CAD 0.32, beating estimates by 5.3%, while revenue of CAD 224.8m was slightly below expectations. Net income rose 69% year-on-year to CAD 19.5m, gross margin improved to 39.2%, and adjusted EBITDA reached CAD 47.6m (21.2% margin). The stock rose 2.66% after the close. For 2025 Savaria forecasts full-year revenue of around CAD 925m and an adjusted EBITDA margin just above 20%, with a focus on expansion, product launches and an investor day in April 2026. » Mere på de.investing.com
Savaria announces monthly dividend of 4.67 cents per share

Savaria will pay a monthly dividend of 4.67 cents (US$0.0467) per common share, payable on November 12, 2025 to shareholders of record on October 31, 2025. The distribution is considered an eligible dividend under the Canadian Income Tax Act. Savaria, a manufacturer of accessibility solutions with a global presence, has a market capitalization of US$686.1 million and a gross profit margin of 52.59%. » Mere på de.investing.com

Historisk udbytte Udbytte

Alle nøgletal for udbytte Alle nøgletal

I 2026 har SAVARIA CORP. allerede udloddet 0,32 € i udbytte. Den seneste udlodning fandt sted i november.

Virksomhedstal

I det seneste kvartal havde SAVARIA CORP. en omsætning på 151,95 mio. € og et nettoresultat på 14,3 mio. €

(EUR)	september 2026	YoY
Omsætning	151,95 mio.	10,47 %
Bruttofortjeneste	59,76 mio.	10,80 %
Nettoresultat	14,3 mio.	19,99 %
EBITDA	30,2 mio.	15,59 %

Fundamentale data

Nøgletal	Værdi
Markedsværdi	1,38 mia. €
Antal aktier	72,27 mio.
Højeste/laveste i 52 uger	20,26 € - 13,14 €
Udbytteafkast	1,87 %
Udbytte TTM	0,35 €
Beta	0,97
P/E (PE Ratio)	23,61
PEG (PEG Ratio)	0,48
K/I (PB Ratio)	3,11
P/S (PS Ratio)	2,26

Virksomhedsprofil

Savaria Corporation leverer tilgængelighedsløsninger til ældre og fysisk udfordrede personer i Canada, USA, Europa og internationalt. Virksomheden er opdelt i tre segmenter: Accessibility, Patient Care og Adapted Vehicles. Accessibility-segmentet designer, fremstiller, distribuerer og installerer tilgængelighedsprodukter, såsom trappeliftstole til lige og buede trapper, lodrette og skrå kørestolsplatformslifte til kommercielle og private boliger samt tilgængelighedselevatorer og hjemmeelevatorer. Patient Care-segmentet fremstiller og distribuerer terapeutiske støttemadrasser og andre trykaflastningsprodukter til det medicinske område og medicinske senge, og tilbyder desuden medicinsk udstyr og løsninger til sikker håndtering af patienter. Adapted Vehicles-segmentet udbyder distribution af køretøjer til personer med mobilitetsudfordringer, til privat eller erhvervsmæssig brug. Virksomheden sælger sine produkter gennem forhandlere og via egne butikker direkte til slutbrugere. Savaria Corporation blev grundlagt i 1979 og har hovedkontor i Laval, Canada.